Bicuculline Methiodide is methiodide type of classical GABAA receptor antagonist. It is water soluble and more stable compound in nature. It also registers non-GABA receptor mediated actions such as action on potassium channel and calcium dependent channels.
The global Bicuculline Methiodide market is estimated to grow at a significant CAGR during the forecast period with installation of innovative strategies by key players during the forecast period 2021-2027. The market is broadly segmented into 2 categories as based on the type of product and based on the application. Depending on the type of product, the Bicuculline Methiodide is segmented as low purity (below 97%), purity (above 97% and below 99%) and high purity (above 99%). Additionally, depending on the end use or application, it is into medical treatment and bioscience research.
Meanwhile, the drivers responsible for the growth of the market include increase in the demand for Bicuculline Methiodide in the application segment. For instance, in medical treatment and in bioscience research, the gradual use of the product and improved installation of the product registered its significant growth. The technological advancement and new products developments are the major strategies adopted by the global market players.
Market Coverage
o By Product type
o By Application
Key questions addressed by the report
o Recovery Timeline
o Deviation from pre-COVID forecast
o Most affected region and segment
Global Bicuculline Methiodide Market Report Segment
By Product Type
o Low Purity (Below 97%)
o Purity (Above 97% and Below 99%)
o High Purity (Above 99%)
o Others
By Application
o Medical Treatment
o Bioscience Research
o Others
Global Bicuculline Methiodide Market Report Segment by Region
North America
Europe
Asia-Pacific
Rest of the World